Literature DB >> 17518655

In vivo osteogenic differentiation of rat bone marrow stromal cells in thermosensitive MPEG-PCL diblock copolymer gels.

M S Kim1, Sun Kyung Kim, Soon Hee Kim, Hoon Hyun, Gilson Khang, Hai Bang Lee.   

Abstract

Methoxy poly(ethylene glycol)-poly(epsilon-caprolactone) (MPEG-PCL) diblock copolymers were prepared by ring-opening polymerization and their phase transition behavior characterized as a function of temperature. The MPEG-PCL solutions formed a sol at room temperature, and underwent sol-to-gel followed by gel-to-sol phase transitions as the temperature was increased. The temperature range over which the solutions were in a gel state could be extended simply by increasing the PCL chain length in the diblock copolymer. Scanning electron microscopy (SEM) images of MPEG-PCL solutions in the sol and gel states revealed near-regular and irregular porous structures, respectively. in vitro culture of rat bone marrow stromal cells (rBMSCs) on gel surfaces exhibited mostly round cells after 1 day of incubation. SEM images of the attached cells clearly showed the cell body and anchoring filopodia. Injection of room-temperature diblock copolymer solutions into Sprague-Dawley rats produced a gel at body temperature. In situ gel-forming scaffolds in vivo were successfully fabricated by simple subcutaneous injection of MPEG-PCL diblock copolymer solutions. The gel implants retained their original shape for 4 weeks without in- flammation at the injection site. Gel implants removed after 4 weeks were found to be surrounded by a thin fibrous capsule consisting of fibroblasts and blood vessels cells. Hematoxylin and eosin (H&E) and von Kossa staining revealed bone formation in gel implants containing both rBMSCs and dexamethasone, with the degree of bone formation increasing markedly with increasing dexamethasone concentration. Thus, our results show that in situ gel scaffolds fabricated from MPEG-PCL diblock copolymer solutions containing dexamethasone enable multipotent rBMSCs to produce viable bone when injected into rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17518655     DOI: 10.1089/ten.2006.12.2863

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  7 in total

Review 1.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

2.  Hydrogels That Allow and Facilitate Bone Repair, Remodeling, and Regeneration.

Authors:  Aaron R Short; Deepthi Koralla; Ameya Deshmukh; Benjamin Wissel; Benjamin Stocker; Mark Calhoun; David Dean; Jessica O Winter
Journal:  J Mater Chem B       Date:  2015-09-03       Impact factor: 6.331

3.  Biodegradable PEG-Based Amphiphilic Block Copolymers for Tissue Engineering Applications.

Authors:  Artem B Kutikov; Jie Song
Journal:  ACS Biomater Sci Eng       Date:  2015-05-26

4.  Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response.

Authors:  Matthew J Webber; John B Matson; Vibha K Tamboli; Samuel I Stupp
Journal:  Biomaterials       Date:  2012-06-28       Impact factor: 12.479

5.  Cellularizing hydrogel-based scaffolds to repair bone tissue: How to create a physiologically relevant micro-environment?

Authors:  Mathieu Maisani; Daniele Pezzoli; Olivier Chassande; Diego Mantovani
Journal:  J Tissue Eng       Date:  2017-06-08       Impact factor: 7.813

6.  In Vivo Osteogenic Differentiation of Human Embryoid Bodies in an Injectable in Situ-Forming Hydrogel.

Authors:  Da Yeon Kim; Yoon Young Kim; Hai Bang Lee; Shin Yong Moon; Seung-Yup Ku; Moon Suk Kim
Journal:  Materials (Basel)       Date:  2013-07-17       Impact factor: 3.623

Review 7.  Self-Assemblable Polymer Smart-Blocks for Temperature-Induced Injectable Hydrogel in Biomedical Applications.

Authors:  Thai Thanh Hoang Thi; Le Hoang Sinh; Dai Phu Huynh; Dai Hai Nguyen; Cong Huynh
Journal:  Front Chem       Date:  2020-01-31       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.